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Abstract
Background: Long noncoding RNA nuclear paraspeckle assembly transcript 1 (NEAT1) plays key role in the progression
of some human cancers. However, the role of NEAT1 in human laryngeal squamous cell cancer (LSCC) is still unknown.
We therefore investigated the expression and function of NEAT1 in LSCC.
Methods: NEAT1 level in LSCC and adjacent non-neoplastic tissues were detected by qRT-PCR. NEAT1 was knockdown in
LSCC cells and cell proliferation, apoptosis and cell cycle were examined. The growth of xenografts with NEAT1
knockdown LSCC cells was analyzed.
Results: NEAT1 level was significantly higher in LSCC than in corresponding adjacent non-neoplastic tissues, and
patients with neck nodal metastasis or advanced clinical stage had higher NEAT1 expression. Moreover, siRNA
mediated NEAT1 knockdown significantly inhibited the proliferation and induced apoptosis and cell cycle arrest
at G1 phase in LSCC cells. The growth of LSCC xenografts was significantly suppressed by the injection of NEAT1
siRNA lentivirus. Furthermore, NEAT1 regulated CDK6 expression in LSCC cells which was mediated by miR-107.
Conclusion: NEAT1 plays an oncogenic role in the tumorigenesis of LSCC and may serve as a potential target for
therapeutic intervention.
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Background
Laryngeal squamous cell carcinoma (LSCC) is one of the
most common malignancies in the head and neck [1].
Despite the improvements in diagnostic and therapeutic
modalities, the survival of laryngeal cancer patients is
still poor over the past 20 years. Therefore, revealing the
molecular mechanism underlying LSCC development is
important for developing effective therapy. Recently, we
and others have focused on the role of aberrant expres-
sion of noncoding RNAs in LSCC [2–6]. Noncoding
RNAs, which do not encode protein, include short
noncoding RNAs and long noncoding RNAs (lncRNAs). By
binding to specific sequences usually in the 3′ untranslated
region (3′UTR) to degrade the transcription of target genes,
microRNAs have been demonstrated to play important role
in multiple cancers including LSCC [2–7]. Long noncoding
RNAs are a class of transcripts longer than 200 nucleotides.
Recent studies have shown that lncRNAs are frequently
dysregulated in cancer progression [8, 9]. Nuclear para-
speckle assembly transcript 1 (NEAT1) lncRNA is found to
localize specifically to paraspeckles which has two isoforms:
3.7 kb NEAT1-1 and 23 kb NEAT1-2 [10]. They share
the same 5′-end but are processed alternatively at the
3′-termini. NEAT1 may serve as a core structural com-
ponent because knockdown of NEAT1 led to the disin-
tegration of paraspeckles [10]. NEAT1 upregulation has
been reported in human malignancies, including
leukemia, hepatocellular carcinoma and lung cancers
[11–13]. However, little is known about whether
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NEAT1 affects carcinogenesis and biological behavior
of LSCC. Our preliminary experiments with microarray
analysis showed that NEAT1 was upregulated in LSCC
tissues (data not shown). In the present study, we fur-
ther detected the expression of NEAT1 in LSCC by
using real-time PCR and found that lncRNA NEAT1
was up-regulated and correlated with the progression
of LSCC. Next, we investigated the function of NEAT1
in LSCC cells and found that NEAT1 knockdown
inhibited the proliferation and invasion of LSCC cells.
Furthermore, we demonstrated that NEAT1 upregu-
lated cyclin-dependent kinase 6 (CDK6) through inhi-
biting the expression of miR-107. These results provide




Pairs of tumor tissues and adjacent non-cancerous
matched tissues were obtained from 52 patients who
underwent partial or total laryngectomy between August
2013 and December 2014 at the Department of Otorhino-
laryngology, the Second Affiliated Hospital of Harbin
Medical University, under an approved protocol of Harbin
Medical University. The patients had not received any
cancer therapy before admission. After surgery, the tissues
obtained from patients were preserved in liquid nitrogen
within 5 min of excision and then were transported frozen
to the laboratory and stored at −80 °C.
Quantitative real-time PCR analysis
Total RNA was extracted by using Trizol reagent (Invitro-
gen, Carlsbad, CA, USA). 2 μg of total RNA were reversely
transcribed to cDNA by using High Capacity cDNA Re-
verse Transcription Kits (Applied Biosystems, Foster City,
CA, USA). Quantitative PCR was performed using Power
SYBR Green RT-PCR Reagents (Applied Biosystems, Foster




reverse, 5′-GCAGGGTCCGAGGTATTC-3′. All reactions
were carried out on the Applied Biosystems 7000 Sequence
Detection System (Applied Biosystems, Foster City, CA,
USA). Relative mRNA and lncRNA levels were normalized
against β-actin and U6 snRNA, respectively, and calculated
using the 2-ΔΔCt method.
Cell culture and virus transduction
Human LSCC cell line Hep-2 was cultured in Dulbecco’s
modified Eagle’s medium containing 10 % fetal bovine
serum (Gibco; Life Technologies, Carlsbad, CA) in a
humidified incubator at 37 °C with 5 % CO2. SiRNAs of
human NEAT1 lentivirus and vector harboring green
fluorescent protein (GFP) and the control lentivirus (GFP-
lentivirus) were constructed by Genechem (Shanghai,
China). The siRNAs sequences targeting NEAT1 were as
follows: 5′-GUGAGAAGUUGCUUAGAAACUUUCC-3′
(siRNA-1) and 5′-GATCCCTAAGCTGTAGAACAT-3′
(siRNA-2). The lentiviruses for the overexpression and
knockdown of miR-107 were provided by Genechem
(Shanghai, China). The lentiviruses were diluted in 0.2 mL
complete medium at 107 transduction units (TU)/mL con-
taining hexadimethrine bromide (Polybrene; 8 mg/mL) and
were incubated with the cells for 1 h at 37 °C. Next, the
cells were incubated with 0.3 mL fresh prepared Polybrene-
Dulbecco’s modified Eagle’s medium for 24 h; the medium
was then replaced with fresh Dulbecco’s modified Eagle’s
medium and the cells were cultured for 48 h.
Cell proliferation assay
The proliferation of Hep-2 cells was evaluated using cell
count kit 8 (CCK-8) cell proliferation kit according to the
manufacturer’s instructions. Briefly, the cells were seeded
into 96-well plates at 5 × 103 cells/well and cultured for
48 h. Then 10 μl CCK-8 solution were added to each well
and incubated for 1 h. The absorbance (A) at 450 nm was
measured using a microplate reader. Results were repre-
sentative of three individual experiments in triplicate.
Wound-healing migration assay
Cells were seeded in 6-well plates and grown to about 90 %
confluence before being wounded using a 200-mL plastic
tip across the monolayer cells. Debris was removed by
washing three times with phosphate-buffered saline (PBS),
and then cells were cultured with fresh DMEM containing
5 % FBS. Wound healing was observed at different time
points within the scrape line, and representative scrape lines
for each cell line were photographed. The migration of the
cells was evaluated by measuring the width of the wounds
(at × 400 magnification). Images were captured immediately
after 24 h post-wounding. Each assay was performed in
triplicate in at least two independent experiments.
Transwell assay
Transwell filters (pore size, 8 μm; Falcon; BD Biosciences)
were coated on the lower side with 8 μg/μL Matrigel and
placed on a 24-well plate containing DMEM. Hep-2 cells
(1 × 105) were added to the upper compartment of a trans-
well chamber and allowed to migrate for 24 h at 37 °C. The
cells were then harvested and suspended in DMEM with
1 % bovine serum albumin. After 24 h, Matrigel and cells
remaining on the upper side of the membrane were wiped
off with cotton swabs, and the cells that had migrated to
the bottom surface of the membrane were fixed in 3.7 %
paraformaldehyde in PBS. Once fixed, the cells were stained
with crystal violet for 10 min at room temperature. Cell in-
vasion was quantified by counting the number of cells in
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three inserts. Data were expressed as the average number
of cells per insert.
Cell cycle analysis
Cells were collected and fixed with cold ethanol at 4 °C for
1 h before being stored at −20 °C. Fixed cells were washed
and resuspended in 1 mL PBS containing 50 μg/mL RNase
A and 50 μg/mL ethidium bromide. After incubating for
20 min at 37 °C, cells were analyzed for DNA content by
flow cytometry (FACS Calibur; Becton Dickinson Immuno-
cytometry Systems, San Jose, CA, USA). For each sample,
20,000 events were acquired, and cell cycle distribution was
determined using cell cycle analysis software (Modfit; LT
for mac V 3.0).
Apoptosis assay by flow cytometry
The cells were washed twice with cold 10 mM PBS and re-
suspended in 1 × binding buffer (BD Biosciences, San José,
CA, USA) at a concentration of 1 × 106 cells/ml. Cells were
stained with Annexin V/ APC and propidium iodide (PI),
using the Annexin V apoptosis detection kit (KeyGen Bio-
tech, Nanjing, China). Hep-2 cells without any treatment
were used as control, and the experiments were repeated at
least three times.
Animal experiments
Sixteen BALB/c mice (5 to 6 weeks old) were provided by
Vital River Laboratories (Beijing, China) and kept in aseptic
conditions with a constant humidity and temperature ac-
cording to standard guidelines under a protocol approved
by Harbin Medical University. All mice were injected sub-
cutaneously in the dorsal scapula region with 100 μL sus-
pension (1 × 106) of Hep-2 cells. The size of the tumor was
measured twice a week with calipers, and the volume of
tumor was determined using the simplified formula of a ro-
tational ellipsoid (length ×width2 × 0.5). Once tumors
reached approximately 0.5 to 0.6 cm3, mice received an in-
jection into the tumor once a week for 3 weeks. Mice in
the experimental group (n = 8) were treated with
100 μL NEAT1 siRNA lentivirus; mice in the control
group (n = 8) received an injection of 100 μL GFP
lentivirus. Tumors were harvested 1 week after the
end of treatment.
Transmission electron microscopy
Apoptotic morphological changes of cells were detected
by transmission electron microscopy. Tumor tissues were
fixed for 1 h with 2.5 % glutaraldehyde using 0.1 mol/L Na
cacodylate buffer (pH 7.3), and then postfixed with 1 % os-
mium tetroxide for 1 h. Fixed samples were rinsed and
dehydrated in a graded ethanol series. Ultrathin sections
were cut, mounted on copper grids, and stained with ur-
anyl acetate and lead citrate by standard methods. Stained
grids were examined and photographed in a JEM 1200 EX
transmission electron microscope (Tokyo, Japan).
TUNEL assay
Apoptosis in vivo was detected using the terminal
deoxytransferase-mediated dUTP nick end labeling
(TUNEL) in situ apoptosis detection kit (Roche) according
to the manufacturer’s instructions. After deparaffinization
and dehydration and inactivation of peroxidase activity, 20
paraffin sections of each tumor specimen were incubated
with 2 μg/mL proteinase K at 37 °C for 15 min. Then, the
sections were treated with terminal deoxynucleotidyl
transferase (TdT) and biotinylated dUTP, and observed
under microscopy. Controls were treated in the same
manner except that TdT was replaced with dH2O.
Western blot analysis
Hep-2 cells were collected and CDK6 expression was de-
tected as described previously using CDK6 antibody (1:400
dilution, Boster, Wuhan, China) [14]. Glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) was used as a loading
control.
Luciferase report assay
3′UTR of CDK6 gene harboring miR-107 binding site was
inserted downstream of firefly luciferase (f-luc) in pGL3
plasmid and named as 3′UTR. 3′UTR of CDK6 gene with
the deletion of miR-107 binding site was inserted down-
stream of f-luc in pGL3 plasmid and named as 3′UTR-NC.
3′UTR of CDK6 gene with three mismatch mutations in
miR-107 seed complementary site was inserted down-
stream of f-luc in pGL3 plasmid and named as 3′UTR-
MU. HEK293T cells were cultured in 96-well plates and co-
transfected with 400 ng of either 3′UTR, 3′UTR-NC or 3′
UTR-MU, 50 ng of pRL-TK (Promega, USA) and 50 nmol/
L of miR-107 or scramble miRNA negative control (miR-
NC). The pRL-TK Renilla luciferase plasmid was used as
internal control. 48 h after transfection, firefly and Renilla
luciferase activities were measured using the dual-luciferase
reporter assay (Promega, USA). The results were expressed
as relative luciferase activity (firefly luciferase/Renilla
luciferase).
Statistical analysis
All quantitative data were presented as the mean ± SD of
at least three independent experiments. The differences
between groups were analyzed by Student’s t test. P < 0.05
was considered as statistically significant.
Results
NEAT1 is overexpressed in LSCC
qPCR analysis showed that NEAT1 levels were signifi-
cantly higher in LSCC tumor tissues than in adjacent non-
neoplastic tissues (3.041 ± 0.709 fold, P < 0.01). NEAT1
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expression was significantly related with T grade, neck
nodal metastasis, and clinical stage of LSCC (Fig. 1). Tu-
mors with grade T3 to T4, lymph node metastasis, or ad-
vanced clinical stages expressed higher levels of NEAT1.
NEAT1 knockdown inhibits the proliferation and invasion
of LSCC cells
Hep-2 cells transduced with NEAT1 siRNAs showed
lower expression of NEAT1 compared with the control
cells. CCK8 assay showed that NEAT1 knockdown
inhibited Hep-2 cell proliferation at each time point
(24, 48 and 72 h) (Fig. 2). By wound healing assay, we
found that NEAT1 knockdown inhibited Hep-2 cell mi-
gration (Fig. 3). In addition, transwell migration and
Matrigel invasion assay showed that NEAT1 knockdown
inhibited Hep-2 cell migration and invasion (Fig. 4). Taken
together, these results suggest that NEAT1 promotes the
proliferation and invasion of LSCC cells.
NEAT1 knockdown induces G1 phase arrest and
apoptosis of Hep-2 cells
Hep-2 cells transduced with GFP-lentivirus exhibited no
significant changes in cell cycle progression at 72 h post-
transduction compared to untransduced Hep-2 cells
Fig. 1 Expression of NEAT1 in LSCC tissues. Tumors with advanced
clinical stages, with poor differentiation, with T3-4 grade or with
lymph node metastasis expressed higher levels of NEAT1.
*P < 0.05; **P < 0.01
Fig. 2 NEAT1 siRNA inhibited the proliferation of LSCC cells. a and c Expression of NEAT1 was significantly downregulated in Hep-2 cells transduced
with two different NEAT1 siRNAs. b and d Cell proliferation was evaluated using CCK8 assay. The proliferation of Hep-2 cells transduced with
two different NEAT1 siRNAs was decreased at different time point (24, 48, and 72 h, respectively) compared with the controls
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(P > 0.05). However, cells transduced with NEAT1
siRNA remained in the G1 phase compared to control
cells (P < 0.05). Flow cytometric analysis showed that
the percentage of apoptotic cells was significantly
higher in NEAT1 siRNA transduced Hep-2 cells than
in the cells transduced with GFP lentivirus (Fig. 5).
NEAT1 knockdown inhibits the growth of LSCC xenografts
To provide in vivo evidence for the oncogenic role of
NEAT1 in LSCC, we used a xenograft mice model. After
the 16 mice were subcutaneously injected with Hep-2
cells, all of them developed detectable tumors. The
growth of LSCC xenograft was significantly inhibited in
mice treated with NEAT1 siRNA lentivirus, compared
with mice treated with GFP lentivirus. The average
tumor weight in NEAT1 siRNA-treated LSCC xenografts
was significantly lower than that in the control group
(1.085 ± 0.132 g versus 2.487 ± 0.160 g, P < 0.01) (Fig. 6).
NEAT1 knockdown induces the apoptosis of LSCC cells in
vivo
By transmission electron microscopy, we observed typical
apoptotic morphology in the tumor cells in NEAT1 siRNA
treated group, characterized by homogeneous condensation
of chromatin to one side or the periphery of the nuclei. The
inner matrix of some mitochondria showed increased elec-
tron density, typically observed in apoptotic cells. These ul-
trastructural changes were only observed in tumor cells of
NEAT1 siRNA treated group but not in tumor cells of the
control group, which showed intact membranes and intact
Fig. 3 NEAT1 siRNA inhibited the migration of Hep-2 cells. Effect of two different NEAT1 siRNAs on cell migration was determined using scratch-wound
healing migration assays, 24 h post-wounding. a and e Hep-2 cells without any treatment, b and f Hep-2 cells transduced with GFP vector control, c and
g Hep-2 cells transfected with NEAT1 siRNA1 or siRNA2, d and h Cell migration was significantly repressed in Hep-2 cells transduced with NEAT1
siRNAs (**P< 0.01)
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morphology of the organelles. Furthermore, the apoptosis
of tumor cells was detected using TUNEL assay, and the
results showed strong TUNEL staining in NEAT1 siRNA-
Lentivirus treated Hep-2 xenografts. In contrast, nearly no
TUNEL-positive staining was detected in the control xeno-
graft sections (Fig. 7).
NEAT1 regulates CDK6 expression through modulating
miR-107
Based on two databases targetscan (www.targetscan.org)
and starbase (starbase.sysu.edu.cn), we found that CDK6
is a potential target of miR-107 while NEAT1 may acts
as a regulator of miR-107 (Fig. 8a and c). We speculated
Fig. 4 NEAT1 siRNA inhibited the invasion of Hep-2 cells. Transwell assay showed that after incubating for 24 h, the invaded cells that penetrated
the lower surface of the membrane were significantly reduced compared to controls. **P < 0.01. a NEAT1 siRNA-1 group; b NEAT1 siRNA-2 group
Wang et al. Journal of Experimental & Clinical Cancer Research  (2016) 35:22 Page 6 of 11
that there is a regulatory loop among CDK6, miR-107
and NEAT1 in LSCC cells. To confirm the direct inter-
action between miR-107 and its binding site within 3′
UTR of CDK6, we created 3′UTR reporter plasmid and
generated 3′UTR-NC and 3′UTR-MU plasmids as nega-
tive controls. Luciferase reporter assay showed that over-
expression of miR-107 led to a marked decrease of
luciferase activity of 3′UTR but could not decrease the
luciferase activity of 3′UTR-NC and 3′UTR-MU
(Fig. 8b). These results indicate that miR-107 directly
modulate CDK6 expression by binding miR-107 seed
complementary site located in 3′UTR of CDK6. Further-
more, RT-PCR and Western blot analysis showed that
knockdown of NEAT1 in LSCC cells led to increased
level of miR-107 and decreased level of CDK6 protein
(Fig. 8d and e).
To further confirm NEAT1 can regulate CDK6 expres-
sion which is mediated by miR-107, we performed res-
cue experiments. In Hep-2 cells with high expression of
NEAT1, overexpression of miR-107 led to significant re-
duction of CDK6 expression (Compared lane 2 to lane 5,
Fig. 8f ). In contrast, while NEAT1 knockdown decreased
CDK6 expression (compared lane 7 to lane 2, Fig. 8f ),
downregulation of miR-107 (by lentivirus transduction
of Anti-miR-107) could restore CDK6 expression inhib-
ited by NEAT1 knockdown (compared lane 7 to lane 1,
Fig. 8f ). Taken together, these results suggest that
NEAT1 regulates CDK6 expression through modulating
miR-107.
Discussion
lncRNAs are a class of noncoding RNA transcripts with
no or little protein-coding capacity. Recent studies have
suggested that more genomic sequences were tran-
scribed into lncRNAs than protein-coding RNAs [15].
lncRNAs play important role in carcinogenesis [16].
Through regulating gene expression by a variety of
mechanisms, such as transcription, post-transcriptional
processing, chromatin modification and the regulation
of protein function, lncRNAs are involved in multiple
processes of tumorigenesis [17]. However, the function
of lncRNAs in LSCC is not well characterized. Our
Fig. 5 NEAT1 siRNA induced G1 phase arrest and apoptosis of Hep-2 cells. Flow cytometric analysis of the cell cycle of Hep-2 cells in each group:
a blank control, b control lentivirus transduced Hep-2 cells, c NEAT1 siRNA lentivirus transduced Hep-2 cells. The dot plot of the X-axis (FL4) represented
Annexin V fluorescence and the Y-axis (FL2) represented PI fluorescence. d Representative flow histograms of Hep-2 cells without any
treatment. e Representative flow histograms of Hep-2 cells transduced with GFP-lentivirus control. f Representative flow histograms of
Hep-2 cells transduced with NEAT1 siRNA lentivirus
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Fig. 6 NEAT1 siRNA suppressed Hep-2 tumor growth in vivo. a Representative mouse injected with GFP control lentivirus. b Representative
mouse injected with NEAT1 siRNA lentivirus. c Tumor weight in NEAT1 siRNA lentivirus-treated group was significantly less than in the control
group. **P < 0.01. n = 8 mice per group
Fig. 7 Apoptosis array in LSCC xenografts. a Cells in control Hep-2 xenografts had normal membrane, organelles, and nuclear morphology. b
Apoptotic morphologies were found in NEAT1 siRNA treated Hep-2 xenografts. c TUNEL staining showed no obvious apoptotic cells in tumors of
the control group. d Strong brown staining indicated many TUNEL positive apoptotic cells in NEAT1 siRNA treated Hep-2 xenografts
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previous studies showed that lncRNA HOTAIR played
oncologic role in LSCC [18, 19]. In this study, by real-time
PCR we found that lncRNA NEAT1 is overexpressed in
LSCC. NEAT1 is transcribed from the familial tumor syn-
drome multiple endocrine neoplasia (MEN) type 1 locus
on chromosome 11 [20]. Paraspeckles are a new class of
subnuclear bodies and contain RNA-binding proteins in
the interchromatin space of mammalian cells. Paraspeckle
can regulate gene expression by retaining mRNAs for edit-
ing in the nucleus [21]. NEAT1 localizes to paraspeckles
and serves as an architectural component of these nuclear
bodies [22]. Recent studies showed that NEAT1 is upregu-
lated and possesses oncogenic properties in various can-
cers such as lung, breast and prostate cancer [13, 20, 23].
In the present study, our data indicate that NEAT1 RNA
is involved in LSCC aggressiveness. NEAT1 was upregu-
lated in LSCC specimens compared with the control tis-
sues. In particular, patients with grade T3 to T4, lymph
node metastasis, poor differentiation, or advanced clinical
stages expressed higher levels of NEAT1.
Fig. 8 NEAT1 regulates CDK6 through modulating miR-107. a TargetScan database predicated CDK6 as a target of miR-107. b miR-107 decreased
luciferase activity of 3′UTR but not that of 3′UTR-NC and 3′UTR-MU. miR-NC indicated scramble miRNA used as the negative control for miR-107.
**P < 0.01. c Starbase database predicted the target site between CDK6 and miR-107. d Real-time PCR showed that miR-107 level significantly
increased after NEAT1 knockdown in Hep-2 cells. **P < 0.01. e Western blot analysis showed that CDK6 protein level decreased after NEAT1 knockdown
in Hep-2 cells. Lane 1 and 2: control Hep-2 cells; Lane 3 and 4: Hep-2 cells transduced with NEAT1 siRNA. GAPDH was loading control. f Western blot
analysis showed that CDK6 protein level decreased after NEAT1 knockdown in Hep-2 cells, but was restored after the knockdown of miR-107. GAPDH
was loading control
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To further understand the biological function of NEAT1
in LSCC progression, both in vitro and in vivo assays were
performed. Our data showed that siRNA mediated knock-
down of NEAT1 led to significant inhibition of cell prolif-
eration and invasion, while induced cell cycle arrest at G1
phase and apoptosis in LSCC cells. Furthermore, our re-
sults demonstrate that NEAT1 knockdown suppressed
tumor growth in BALB/c mice xenografts and induced
tumor cell apoptosis in vivo. These results indicate that
high expression of NEAT1 promotes the progression of
LSCC and NEAT1 plays oncogenic role in LSCC.
The molecular mechanism of NEAT1 is complex. Hir-
ose et al. suggested that paraspeckles/NEAT1 attenuated
the cell death pathway [24]. Choudhry et al. showed that
NEAT1 expression correlated with poor survival of
breast cancer and was induced by HIF-2 in hypoxia [20].
Chakravarty et al. identified NEAT1 as a potential target
of ERα in prostate cancer [23]. Moreover, NEAT1 was
reported to be regulated by miR-449a in lung cancer
[25]. miR-107 belongs to the miR-103/107 family and
functions as a tumor suppressor in multiple cancers in-
cluding head and neck squamous cell carcinoma [26].
CDK6, a member of the CDK family, is a key regulator
during the G1/S cell cycle transition. Cdk6 is highly
expressed in head and neck squamous cell carcinoma
and significantly correlates with tumor progression [27].
Targetscan predicted that CDK6 may be a target of miR-
107 and Starbase database suggested the target sites be-
tween NEAT1 and miR-107. Thus, we speculated that
NEAT1 can regulate CDK6 thorough miR-107 network
in LSCC. Through luciferase reporter assay, we found
that CDK6 is a direct target gene of miR-107. Further-
more, we showed that NEAT1 siRNA increased miR-107
level and decreased CDK6 protein level. These results
are consistent with our predication and suggest that
NEAT1 can regulate CDK6 through miR-107. These
data provide new insights into noncoding RNA regula-
tion network, suggesting that lncRNA not only regulate
proteins but also modulate the target gene of miRNA in-
directly through affecting miRNA expression.
Conclusions
This is the first study to demonstrate oncogenic role of
NEAT1 in LSCC. The molecular mechanism of NEAT1
function in LSCC is associated with the regulation of
miR-107/CDK6 pathway. NEAT1 may serve as a marker
for LSCC progression and a potential target for thera-
peutic intervention of LSCC.
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